Dubai, UAE: 

NMC, the largest private healthcare provider in the Middle East, was presented with the ‘UAE Deal of the Year’ award for their five-year USD$400m Sukuk transaction at the Islamic Finance News (IFN) Awards 2019.

Commenting on the win, Prasanth Manghat CEO of NMC Healthcare, said: “I am very pleased to accept the UAE Deal of the Year Award; this would not have been possible without the trust and faith investors have shown in us.”

Prasanth Manghat added: “Providing healthcare since 1975, NMC continues to grow and expand, and this award provides further incentive to help accomplish our present and future goals.”

At the prestigious IFN Awards 2019 several big names in the industry compete for a range of recognitions which are judged primarily under two categories, the Best Bank Polls, and Deals of the Year. Leading industries across the region were judged based on their contribution to the Islamic debt capital market space.

Honouring leaders in the Islamic debt capital market, the winners of the coveted IFN Awards are chosen based on feedback and votes from stakeholders.

-Ends-

About NMC Health

NMC Health PLC is the leading private sector healthcare operator based out of the United Arab Emirates. The group, having started its operations in the country in 1975, has an international network of hospitals in the UAE & GCC, Europe and South America consisting of over 145 healthcare facilities across 13 countries, catering to over 8.5 million patients per year, and employing over 2000 doctors and 18000 administrative and support staff.

The group is also a leading UAE distributor of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Trading, a subsidiary of NMC Health PLC, is one of the largest distributors in the UAE with distribution rights for some of the most iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others. NMC Trading sells products and services to over 10,000 businesses across the UAE.

NMC Health PLC reported revenues of US$1603.4 m in 2017. In April 2012 NMC Health PLC became the first healthcare company from the GCC to list on the London Stock Exchange (LSE). NMC Health PLC is a constituent of the coveted FTSE 100 Index of the blue-chip companies at the LSE.

To   find   out   more   visit: https://nmc.ae/ 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.